Qube Research & Technologies (QRT)
BVS icon

Qube Research & Technologies (QRT)’s Bioventus BVS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-133,021
Closed -$1.21M – 3504
2026
Q1 		$1.21M Sell
133,021
-315,985
-70% -$2.65M ﹤0.01% 2410
2025
Q4 		$3.34M Sell
449,006
-76,097
-14% -$547K ﹤0.01% 1994
2025
Q3 		$3.51M Buy
525,103
+106,515
+25% +$739K ﹤0.01% 1956
2025
Q2 		$2.77M Buy
418,588
+58,358
+16% +$414K ﹤0.01% 2040
2025
Q1 		$3.3M Buy
360,230
+106,201
+42% +$1.06M ﹤0.01% 1746
2024
Q4 		$2.67M Buy
254,029
+108,481
+75% +$1.28M ﹤0.01% 1765
2024
Q3 		$1.74M Sell
145,548
-99,459
-41% -$860K ﹤0.01% 1810
2024
Q2 		$1.41M Sell
245,007
-46,206
-16% -$253K ﹤0.01% 1762
2024
Q1 		$1.51M Buy
291,213
+112,754
+63% +$551K ﹤0.01% 1907
2023
Q4 		$940K Buy
178,459
+154,936
+659% +$613K ﹤0.01% 1964
2023
Q3 		$77.6K Sell
23,523
-67,522
-74% -$237K ﹤0.01% 2742
2023
Q2 		$263K Buy
+91,045
New +$175K ﹤0.01% 1698

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BVS Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Bioventus (BVS) in Q2 2026, closing a stake of 133,021 shares — an estimated $1.21M sold.

Qube Research & Technologies (QRT) first reported a position in BVS in Q2 2023 and held it in 12 quarters. The position peaked at $3.51M in Q3 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 133,021 Bioventus shares in Q2 2026, an estimated $1.21M.
  • Qube Research & Technologies (QRT) first reported a position in Bioventus in Q2 2023 and held it in 12 quarters.
  • Qube Research & Technologies (QRT)'s Bioventus position peaked at $3.51M in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.